Trip.com: Post-SAMR Reality Shifts The Narrative To A 'Show-Me' Story; Reiterate Neutral

Trip.com reported Q2 2026 revenue growth of 6% year over year, in line with guidance, while international business expanded 50%. Regulatory-mandated dismantling of its core monetization and ranking algorithms raises competitive pressure, pricing-power risks and potential domestic market-share losses. TCOM trades at 9x forward earnings, a valuation reflecting investor caution over the regulatory outlook.

Analysis

The valuation discount is less about a single-quarter growth print than whether Trip.com can preserve take rate as mandated changes make ranking less commercially optimized. A lower ability to steer traffic toward higher-commission hotels, preferred suppliers, and proprietary packages would pressure gross margin before it is visible in reported revenue; hotel commissions and advertising economics are the key earnings variables to monitor over the next two reporting periods. The market is likely to treat any deceleration in revenue per room night or hotel/air gross-margin commentary as evidence that the earnings multiple deserves to remain depressed.

International growth is strategically valuable because overseas outbound and cross-border bookings can diversify regulatory exposure and may carry a different supplier mix, but it is not automatically margin-accretive. Customer-acquisition spending, localized inventory, payment costs, and competition from Booking Holdings (BKNG), Expedia (EXPE), and regional platforms could consume much of the incremental contribution margin for 6-18 months. Conversely, stronger international scale raises the probability that TCOM becomes a more consequential distribution partner for Asian hotel chains, improving negotiated inventory and eventually offsetting domestic take-rate pressure.

Consensus may be too focused on the headline regulatory risk and insufficiently focused on the asymmetry at 9x forward earnings: a stable domestic conversion rate plus sustained international growth could produce multiple expansion even without a domestic share gain. The falsification point is not a near-term share-price level; it is two consecutive quarters of declining monetization per transaction, a material step-up in sales and marketing as a share of revenue, or guidance implying that international growth is being purchased rather than monetized.

Key Decisions for Investors

• Maintain TCOM as a watch-to-buy rather than an immediate outright long; initiate only after the next earnings release confirms stable hotel/air monetization and no material increase in customer-acquisition expense. Target a 6-12 month re-rating from 9x toward 11-12x forward earnings if those metrics hold; exit on two-quarter take-rate deterioration.
• For existing exposure, use a 3-6 month TCOM/BKNG relative-value pair: long TCOM and short BKNG only if TCOM demonstrates international contribution-margin resilience. The trade isolates a potential valuation catch-up, but fails if Chinese platform rules structurally impair supplier economics or BKNG takes outbound China share.
• Track quarterly revenue per booking, adjusted EBITDA margin, sales-and-marketing intensity, and management disclosure on ranking-related conversion. A 100-150 bp margin decline attributable to monetization changes should trigger a reduction in TCOM exposure, irrespective of top-line international growth.
• Avoid treating international growth as a standalone catalyst until management provides evidence of repeat booking and contribution profitability by geography; absent that data, higher overseas mix may be a near-term earnings drag rather than a multiple-expansion driver.